In continuation to our communication in accordance SERI Circular No. SEBI/HO/MIRSD/DOP/CIR/P/2020/28
dated February 25, 2020 in connection with the Pledge and Re-Pledge of securities
with Clearing Member / Clearing Corporation.
Bafna Towers,New No 68, Old No.299,Thambu Chetty Street,Chennai,Tamil Nadu-600001
Bafna Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 142.1. Its current market capitalisation stands at Rs 330.95 Cr. In the latest quarter, company has reported Gross Sales of Rs. 424.73 Cr and Total Income of Rs.427.28 Cr. The company's management includes Atul Sachdeva, Ravichandran Chitra, Akilapriya Chandrashekar Raju, Palamadi Krishnan Sundaresan, Jitendra Kumar Pal, B Kamlesh Kumar, Shanmugam Hemalatha, Bafna Mahaveer Chand. It is listed on the BSE with a BSE Code of 532989 , NSE with an NSE Symbol of BAFNAPH and ISIN of INE878I01022. It's Registered office is at Bafna Towers,New No 68, Old No.299,Thambu Chetty StreetChennai-600001, Tamil Nadu. Their Registrars are ACC Ltd. It's auditors are Abhay Jain & Co, R Sathyanarayanan & Co
© NIRMAL BANG. All rights reserved
Designed , Developed & Content Powered by ●●●
Accord Fintech Pvt. Ltd.
Please fill in the details below
(Note - You will receive a call from our sales executive)
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document,
Do's & Don't's) in Vernacular Language :